Avricore Health Inc. (FRA:8VP1)

Avricore Health Statistics

Total Valuation

Avricore Health has a market cap or net worth of EUR 3.13 million. The enterprise value is 2.59 million.

Market Cap	3.13M
Enterprise Value	2.59M

Important Dates

The last earnings date was Friday, November 28, 2025.

Earnings Date	Nov 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	101.29M
Shares Outstanding	n/a
Shares Change (YoY)	+1.33%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	8.60%
Owned by Institutions (%)	n/a
Float	92.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.63
PB Ratio	3.09
P/TBV Ratio	3.23
P/FCF Ratio	19.41
P/OCF Ratio	12.54
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.91
EV / Sales	1.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	16.10

Financial Position

The company has a current ratio of 20.44

Current Ratio	20.44
Quick Ratio	19.48
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -73.26% and return on invested capital (ROIC) is -18.87%.

Return on Equity (ROE)	-73.26%
Return on Assets (ROA)	-17.17%
Return on Invested Capital (ROIC)	-18.87%
Return on Capital Employed (ROCE)	-36.31%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.44
Inventory Turnover	253.87

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.57% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-28.57%
50-Day Moving Average	0.03
200-Day Moving Average	0.03
Relative Strength Index (RSI)	52.01
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Avricore Health had revenue of EUR 1.92 million and -891,486 in losses. Loss per share was -0.01.

Revenue	1.92M
Gross Profit	825,942
Operating Income	-367,455
Pretax Income	-891,486
Net Income	-891,486
EBITDA	-181,317
EBIT	-367,455
Loss Per Share	-0.01

Balance Sheet

The company has 540,165 in cash and n/a in debt, giving a net cash position of 540,165.

Cash & Cash Equivalents	540,165
Total Debt	n/a
Net Cash	540,165
Net Cash Per Share	n/a
Equity (Book Value)	1.01M
Book Value Per Share	0.01
Working Capital	564,917

Cash Flow

In the last 12 months, operating cash flow was 249,270 and capital expenditures -88,229, giving a free cash flow of 161,041.

Operating Cash Flow	249,270
Capital Expenditures	-88,229
Free Cash Flow	161,041
FCF Per Share	n/a

Margins

Gross margin is 42.97%, with operating and profit margins of -19.12% and -46.38%.

Gross Margin	42.97%
Operating Margin	-19.12%
Pretax Margin	-46.38%
Profit Margin	-46.38%
EBITDA Margin	-9.43%
EBIT Margin	-19.12%
FCF Margin	8.38%

Dividends & Yields

Avricore Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.33%
Shareholder Yield	-1.33%
Earnings Yield	-28.52%
FCF Yield	5.15%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 21, 2016. It was a reverse split with a ratio of 0.25.

Last Split Date	Nov 21, 2016
Split Type	Reverse
Split Ratio	0.25

Scores

Avricore Health has an Altman Z-Score of 127.73 and a Piotroski F-Score of 4.

Altman Z-Score	127.73
Piotroski F-Score	4